Weissleder, Ralph http://orcid.org/0000-0003-0828-4143
Lee, Hakho http://orcid.org/0000-0002-0087-0909
Article History
Accepted: 21 January 2020
First Online: 5 March 2020
Competing interests
: R.W. declares that he has received consultancy payments from Tarveda Pharmaceuticals, ModeRNA, Alivio Therapeutics and Accure Health, and that he is a shareholder of T2 Biosystems, Lumicell, Accure Health and Aikili Biosystems. H.L. declares that he has received consultancy payments from Exosome Diagnostics and Accure Health, and that he is a shareholder of Accure Health and Aikili Biosystems. Patents: all patents associated with R.W. and H.L. have been assigned to and handled by Massachusetts General Hospital.